title: Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state.
abstract: BACKGROUND
  Typhoid fever caused by Salmonella enterica serovar Typhi (S. Typhi) remains a serious burden of disease, especially in developing countries of Asia and Africa. It is estimated that it causes 200,000 deaths per year, mainly in children. S. Typhi is an obligate pathogen of humans and although it has a relatively complex life cycle with a long lived carrier state, the absence of non-human hosts suggests that well targeted control methods should have a major impact on disease. Newer control methods including new generations of vaccines offer hope but their implementation would benefit from quantitative models to guide the most cost effective strategies. This paper presents a quantitative model of Typhoid disease, immunity and transmission as a first step in that process.
  
  
  RESULTS
  A stochastic agent-based model has been developed that incorporates known features of the biology of typhoid including probability of infection, the consequences of infection, treatment options, acquisition and loss of immunity as a result of infection and vaccination, the development of the carrier state and the impact of environmental or behavioral factors on transmission. The model has been parameterized with values derived where possible from the literature and where this was not possible, feasible parameters space has been determined by sensitivity analyses, fitting the simulations to age distribution of field data. The model is able to adequately predict the age distribution of typhoid in two settings.
  
  
  CONCLUSIONS
  The modeling highlights the importance of variations in the exposure/resistance of infants and young children to infection in different settings, especially as this impacts on design of control programs; it predicts that naturally induced clinical and sterile immunity to typhoid is long lived and highlights the importance of the carrier state especially in areas of low transmission.
authors.affiliation: Novartis Vaccines Institute for Global Health, Siena, Italy.
authors.forename: Allan
authors.initials: A
authors.lastname: Saul
authors.forename: Tom
authors.initials: T
authors.lastname: Smith
authors.forename: Nicolas
authors.initials: N
authors.lastname: Maire
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000465:Algorithms; D002353:Carrier State / Q000276:immunology / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D003198:Computer Simulation; D058872:Epidemics; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D012307:Risk Factors; D012485:Salmonella typhi / Q000276:immunology; D012621:Seasons; D013269:Stochastic Processes; D014435:Typhoid Fever / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D014436:Typhoid-Paratyphoid Vaccines / Q000276:immunology; D055815:Young Adult
chemical_list: D014436:Typhoid-Paratyphoid Vaccines
references.citation: J Pediatr. 1984 Jun;104(6):899-901
references.pmid: 6427437
references.citation: Pediatr Infect Dis J. 2001 May;20(5):521-4
references.pmid: 11368111
references.citation: J Infect Dis. 1982 Dec;146(6):724-6
references.pmid: 7142746
references.citation: J Infect Dev Ctries. 2010 Jun 30;4(6):404-11
references.pmid: 20601795
references.citation: Bull World Health Organ. 1971;45(1):53-75
references.pmid: 5316853
references.citation: Infect Immun. 1999 Nov;67(11):5806-10
references.pmid: 10531232
references.citation: Adv Exp Med Biol. 2011;697:17-39
references.pmid: 21120717
references.citation: Bull World Health Organ. 2008 Apr;86(4):260-8
references.pmid: 18438514
references.citation: N Engl J Med. 2009 Jul 23;361(4):335-44
references.pmid: 19625715
references.citation: Arch Dis Child. 1996 Sep;75(3):214-7
references.pmid: 8976660
references.citation: Vaccine. 2009 Mar 4;27(10):1609-21
references.pmid: 19146902
references.citation: Bull World Health Organ. 2006 Mar;84(3):181-8
references.pmid: 16583076
references.citation: Trans R Soc Trop Med Hyg. 2006 Aug;100(8):725-33
references.pmid: 16455118
references.citation: Wkly Epidemiol Rec. 2008 Feb 8;83(6):49-59
references.pmid: 18260212
references.citation: Bull World Health Organ. 1971;45(4):445-50
references.pmid: 4948415
references.citation: Int J Infect Dis. 2006 Jul;10(4):309-14
references.pmid: 16412678
references.citation: Am J Trop Med Hyg. 2000 May;62(5):644-8
references.pmid: 11289678
references.citation: Int J Infect Dis. 2006 May;10(3):215-22
references.pmid: 16431148
references.citation: N Engl J Med. 1970 Sep 24;283(13):686-91
references.pmid: 4916913
references.citation: BMC Infect Dis. 2009 Nov 27;9:187
references.pmid: 19943919
references.citation: Bull World Health Organ. 2004 May;82(5):346-53
references.pmid: 15298225
references.citation: Vaccine. 1996 Apr;14(5):435-8
references.pmid: 8735556
references.citation: Arch Dis Child. 1986 Dec;61(12):1228-30
references.pmid: 3813617
references.citation: Pediatr Infect Dis J. 2010 Nov;29(11):1035-9
references.pmid: 21046701
references.citation: Lancet. 1999 Aug 28;354(9180):734-7
references.pmid: 10475185
references.citation: PLoS One. 2011;6(9):e25398
references.pmid: 21980445
references.citation: PLoS One. 2010 Nov 15;5(11):e13988
references.pmid: 21085575
references.citation: Arch Dis Child. 1975 Jan;50(1):67-71
references.pmid: 804867
references.citation: J Hyg (Lond). 1953 Jun;51(2):260-7
references.pmid: 13069708
references.citation: N Engl J Med. 1970 Oct 1;283(14):739-46
references.pmid: 4916916